Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Oncology|July 12, 2021
Exploratory Analysis of 18F-3'-deoxy-3'-fluorothymidine (18F-FLT) PET/CT-Based Radiomics for the Early Evaluation of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast CancerLorenzo Fantini, Maria Luisa Belli, Irene Azzali, et al.
Clinical Nuclear Medicine|June 26, 2013
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mLMarcelo Mamede, Francesco Ceci, Paolo Castellucci, et al.
Frontiers in Oncology|January 21, 2026
Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trialMonica Celli, Roberta Gunelli, Fabio Ferroni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2016
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
Neuroendocrinology|November 21, 2024
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized StudyIlaria Grassi, Silvia Nicolini, Irene Marini, et al.
JCO Precision Oncology|February 1, 2022
Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA AnalysisVincenza Conteduca, Emanuela Scarpi, Federica Matteucci, et al.
Frontiers in Medicine|February 9, 2026
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomasIlaria Grassi, Maddalena Sansovini, Federica Matteucci, et al.
Therapeutic Advances in Medical Oncology|February 22, 2021
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancerAndrea Rocca, Pietro Cortesi, Laura Cortesi, et al.
Pageof 3